These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34387127)

  • 1. Geriatric Conditions Are Associated With Decreased Anticoagulation Use in Long-Term Care Residents With Atrial Fibrillation.
    Zhang N; Patel J; Chen Z; Zhou Y; Crawford S; McManus DD; Gurwitz J; Shireman TI; Kapoor A
    J Am Heart Assoc; 2021 Aug; 10(16):e021293. PubMed ID: 34387127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geriatric Conditions Predict Discontinuation of Anticoagulation in Long-Term Care Residents With Atrial Fibrillation.
    Kapoor A; Foley G; Zhang N; Zhou Y; Crawford S; McManus D; Gurwitz J
    J Am Geriatr Soc; 2020 Apr; 68(4):717-724. PubMed ID: 31967319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geriatric conditions do not predict stroke or bleeding in long-term care residents with atrial fibrillation.
    Kapoor A; Patel J; Chen Z; Crawford S; McManus D; Gurwitz J; Shireman TI; Zhang N
    J Am Geriatr Soc; 2022 Apr; 70(4):1218-1227. PubMed ID: 34902164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
    Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
    J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and harms of oral anticoagulants for atrial fibrillation in nursing home residents with advanced dementia.
    Ouellet GM; O'Leary JR; Leggett CG; Skinner J; Tinetti ME; Cohen AB
    J Am Geriatr Soc; 2023 Feb; 71(2):561-568. PubMed ID: 36310367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
    Gray MP; Saba S; Zhang Y; Hernandez I
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude.
    Bahri O; Roca F; Lechani T; Druesne L; Jouanny P; Serot JM; Boulanger E; Puisieux F; Chassagne P
    J Am Geriatr Soc; 2015 Jan; 63(1):71-6. PubMed ID: 25597559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and the factors associated with oral anticoagulant use among nursing home residents.
    Chen Q; Lapane K; Nunes AP; Tjia J; Hugunin J; Alcusky M
    J Clin Pharm Ther; 2021 Dec; 46(6):1714-1728. PubMed ID: 34463969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.
    Steinberg BA; Greiner MA; Hammill BG; Curtis LH; Benjamin EJ; Heckbert SR; Piccini JP
    Cardiovasc Ther; 2015 Aug; 33(4):177-83. PubMed ID: 25930214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: The SAGE-AF study.
    Wang W; Saczynski J; Lessard D; Mailhot T; Barton B; Waring ME; Sogade F; Hayward R; Helm R; McManus DD
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2508-2515. PubMed ID: 31515920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.
    Kapoor A; Amroze A; Vakil F; Crawford S; Der J; Mathew J; Alper E; Yogaratnam D; Javed S; Elhag R; Lin A; Narayanan S; Bartlett D; Nagy A; Shagoury BK; Fischer MA; Mazor KM; Saczynski JS; Ashburner JM; Lopes R; McManus DD
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005871. PubMed ID: 32063041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
    Maes F; Dalleur O; Henrard S; Wouters D; Scavée C; Spinewine A; Boland B
    Clin Interv Aging; 2014; 9():1091-9. PubMed ID: 25053883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.
    O'Neal WT; Sandesara PB; Claxton JS; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: Prescription patterns and 30-day outcomes in the United States and Canada.
    Matos JD; McIlvaine S; Grau-Sepulveda M; Jawitz OK; Brennan JM; Khabbaz KR; Sellke FW; Yeh R; Zimetbaum P
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):616-624.e3. PubMed ID: 32197901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHA
    Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
    Coleman CI; Turpie AGG; Bunz TJ; Eriksson D; Sood NA; Baker WL
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):64-69. PubMed ID: 30020424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.